151 related articles for article (PubMed ID: 36806262)
1. Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice.
Kida Y; Okahisa T; Sato Y; Bando M; Fujimoto S; Ma B; Nakagawa T; Kawaguchi T; Nakamura F; Okamoto K; Miyamoto H; Sogabe M; Tsuneyama K; Takayama T
Sci Rep; 2023 Feb; 13(1):2899. PubMed ID: 36806262
[TBL] [Abstract][Full Text] [Related]
2. Inflammation-driven colon neoplasmatogenesis in uPA-deficient mice is associated with an increased expression of Runx transcriptional regulators.
Afaloniati H; Karagiannis GS; Hardas A; Poutahidis T; Angelopoulou K
Exp Cell Res; 2017 Dec; 361(2):257-264. PubMed ID: 29107070
[TBL] [Abstract][Full Text] [Related]
3. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-type plasminogen activator promotes paracellular transmigration of neutrophils via Mac-1, but independently of urokinase-type plasminogen activator receptor.
Reichel CA; Uhl B; Lerchenberger M; Puhr-Westerheide D; Rehberg M; Liebl J; Khandoga A; Schmalix W; Zahler S; Deindl E; Lorenzl S; Declerck PJ; Kanse S; Krombach F
Circulation; 2011 Oct; 124(17):1848-59. PubMed ID: 21969013
[TBL] [Abstract][Full Text] [Related]
5. Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1, and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancer.
Castelló R; Estellés A; Vázquez C; Falcó C; España F; Almenar SM; Fuster C; Aznar J
Clin Chem; 2002 Aug; 48(8):1288-95. PubMed ID: 12142386
[TBL] [Abstract][Full Text] [Related]
6. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-type plasminogen activator modulates mammalian circadian clock phase regulation in tissue-type plasminogen activator knockout mice.
Cooper JM; Rastogi A; Krizo JA; Mintz EM; Prosser RA
Eur J Neurosci; 2017 Mar; 45(6):805-815. PubMed ID: 27992087
[TBL] [Abstract][Full Text] [Related]
8. Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 as a prognostic factor in human colorectal carcinomas.
Fujii T; Obara T; Tanno S; Ura H; Kohgo Y
Hepatogastroenterology; 1999; 46(28):2299-308. PubMed ID: 10521987
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
[TBL] [Abstract][Full Text] [Related]
10. Jianpi Qingchang decoction alleviates ulcerative colitis by inhibiting nuclear factor-κB activation.
Zheng L; Zhang YL; Dai YC; Chen X; Chen DL; Dai YT; Tang ZP
World J Gastroenterol; 2017 Feb; 23(7):1180-1188. PubMed ID: 28275298
[TBL] [Abstract][Full Text] [Related]
11. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.
Li YH; Xiao HT; Hu DD; Fatima S; Lin CY; Mu HX; Lee NP; Bian ZX
Pharmacol Res; 2016 Aug; 110():227-239. PubMed ID: 26969793
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of CPT1A exerts a protective effect in dextran sulfate sodium-induced ulcerative colitis partially by inhibiting PPARα signaling pathway.
Chen W; Zou J; Shi X; Huang H
Drug Dev Res; 2022 Sep; 83(6):1408-1418. PubMed ID: 35749635
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression.
Baker EA; Bergin FG; Leaper DJ
Mol Pathol; 2000 Dec; 53(6):307-12. PubMed ID: 11193049
[TBL] [Abstract][Full Text] [Related]
14. Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis.
Humphries J; Gossage JA; Modarai B; Burnand KG; Sisson TH; Murdoch C; Smith A
J Vasc Surg; 2009 Nov; 50(5):1127-34. PubMed ID: 19703758
[TBL] [Abstract][Full Text] [Related]
15. Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets.
Yang JL; Seetoo Dq; Wang Y; Ranson M; Berney CR; Ham JM; Russell PJ; Crowe PJ
Int J Cancer; 2000 Sep; 89(5):431-9. PubMed ID: 11008205
[TBL] [Abstract][Full Text] [Related]
16. A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis.
Glas M; Popp B; Angele B; Koedel U; Chahli C; Schmalix WA; Anneser JM; Pfister HW; Lorenzl S
Exp Neurol; 2007 Oct; 207(2):350-6. PubMed ID: 17716658
[TBL] [Abstract][Full Text] [Related]
17. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of 7-hydroxyl-1-methylindole-3-acetonitrile on the intestinal mucosal damage response to inflammation in mice with DSS-induced colitis.
Chung KS; Park SE; Lee JH; Kim SY; Han HS; Lee YS; Jung SH; Jang E; Lee S; Lee KT
Chem Biol Interact; 2023 Jan; 370():110316. PubMed ID: 36543318
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator.
Stempien-Otero A; Plawman A; Meznarich J; Dyamenahalli T; Otsuka G; Dichek DA
J Biol Chem; 2006 Jun; 281(22):15345-51. PubMed ID: 16554301
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein e-null mice.
Hu JH; Du L; Chu T; Otsuka G; Dronadula N; Jaffe M; Gill SE; Parks WC; Dichek DA
Circulation; 2010 Apr; 121(14):1637-44. PubMed ID: 20351234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
